Our work in health care is about addressing patients’ critical needs, expanding access to care and helping improve outcomes so people can lead longer, better lives.
Our people upheld rigorous quality processes, delivered market-leading solutions around the world and collaborated with early-stage innovators, partners in health equity and practitioners in the field to expand health care access.
invested in R&D1
effectiveness in corrective and preventive action (CAPA) metrics and 99% on-time approvals
resulting in action following 325+ external audit days
1 Represents GAAP R&D expense per 2022 Annual Report on Form 10-K.
The heart of Kingston
Abi-Gaye Smythe is always on the move. Whether on the job reporting local news, at the gym working out, or busy promoting awareness of heart disease, the Kingston, Jamaica native struggled with cardiac symptoms as a child and was eventually diagnosed with arrhythmogenic right ventricular dysplasia (ARVD). The rare condition, which claimed her mother’s life at age 39, can lead to sudden, early death.
Abi-Gaye was determined to find a solution to her condition. After years of debilitating symptoms and multiple tests, her doctors recommended a small, thin implantable cardioverter defibrillator (ICD) developed by Boston Scientific. Since her last surgery to implant the DYNAGEN™ MINI ICD, Abi-Gaye has been facing down her old fears of dying young.
Now, Abi-Gaye raises awareness of the importance of heart health, organizing blood drives and partnering with non-profit organizations to arrange life-saving heart surgeries for patients in underserved communities in Jamaica.
“This heart device is my baby—it’s given me a second chance at life, and I’m making the most of it. My mother would want me to do all of this. I’m stronger in every way, and I feel like I can do anything.”
– Abi-Gaye Smythe, Boston Scientific DYNAGEN™ MINI implantable cardioverter defibrillator (ICD) patient
Explore our progress
Learn more about our work to improve patient outcomes in 2022.
Boston Scientific is proud to be recognized for our health care innovations that impact patients' lives.
All data as of December 31, 2022 unless otherwise noted.